EADV 2026视频特辑｜Curdin Conrad教授：银屑病个体化诊疗、口服新药与早期干预机会窗口

国际银屑病理事会理事、欧洲皮肤病研究学会（ESDR）前任主席 Curdin Conrad 教授围绕 “银屑病个体化医疗” 核心主题展开深度分享。 Curdin Conrad 教授系统解读了银屑病从临床表型延伸至分子特征的分层诊疗策略，剖析了新型口服疗法的临床定位与未满足的治疗需求，同时结合循证证据探讨了早期干预的疾病修饰效应与治疗机会窗口，为银屑病临床诊疗与前沿研究提供专业视角与实践参考。
Professor Curdin Conrad, Board Member of the International Psoriasis Council (IPC) and former President of the European Society for Dermatological Research (ESDR), delivers an in-depth sharing centred on the core theme of personalised medicine for psoriasis.
He systematically elaborates the stratified diagnostic and therapeutic strategies for psoriasis extending from clinical phenotypes to molecular characteristics, analyzes the clinical positioning and unmet therapeutic needs of novel oral therapies, and explores the disease-modifying effect and therapeutic window of opportunity of early intervention drawing on evidence-based research findings. His insights offer professional perspectives and practical references for the clinical practice and cutting-edge research of psoriasis.